NCT04117451

Brief Summary

The oral microbiome has recently emerged as a key contributor in nitric oxide (NO) homeostasis and vascular control by increasing nitrite bioavailability. Antibacterial mouthwash containing chlorhexidine has been shown to be effective in inhibiting the nitrate-reducing activity of oral bacteria, and increasing blood pressure in normotensive and hypertensive individuals. Recent research has also shown that chlorhexidine mouthwash lowered salivary pH and increased salivary lactate and glucose. This was also associated with changes on the activity and diversity of oral bacteria that are susceptible to increase the risk of periodontal disease. On the other hand, mouthwash containing propolis has similar antimicrobial effects than chlorhexidine, but adding some positive outcomes such as increased salivary antioxidant capacity. This may suggest that propolis mouthwash modulates the activity/diversity of oral bacteria. Thus, this study aims to investigate the effect of propolis mouthwash on the nitrate-reducing activity of oral bacteria and vascular function compared to chlorhexidine in healthy humans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 3, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 7, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2022

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

2.8 years

First QC Date

October 3, 2019

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Enhanced activity of oral bacteria

    The nitrate-reducing nitrate activity of oral bacterial will be measured before and after each treatment

    1 week

  • Enhanced cardiovascular function

    Blood pressure and microvascular response to a hyperaemia reactive test will be measured before and after each treatment

    1 week

Study Arms (2)

Chlorhexidine

SHAM COMPARATOR

Chlorhexidine mouthwash will be provided to participants for a week to rinse the mouth twice a day.

Other: Propolis

Propolis

EXPERIMENTAL

Propolis mouthwash will be provided to participants for a week to rinse the mouth twice a day.

Other: Propolis

Interventions

Investigating the impact of propolis mouthwash on oral and cardiovascular health

ChlorhexidinePropolis

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy individuals between 18 and 50 years old

You may not qualify if:

  • Smoking
  • To have hypertension, dyslipidaemia, diabetes, cancer or other physiological and mental disorders
  • Existing interventions affecting the oral bacteria: mouthwash, tongue scrapes
  • To have taken antibiotics within the last month.
  • In females, to have irregular menstrual periods, less than or greater than 28 days over the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Plymouth

Plymouth, Devon, PL4 8AA, United Kingdom

Location

MeSH Terms

Conditions

Periodontal Diseases

Interventions

Propolis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Resins, PlantBiopolymersPolymersMacromolecular SubstancesPlant ExudatesBiological ProductsComplex Mixtures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 3, 2019

First Posted

October 7, 2019

Study Start

June 5, 2019

Primary Completion

March 30, 2022

Study Completion

May 3, 2022

Last Updated

May 18, 2022

Record last verified: 2022-05

Locations